New Criteria to Identify Patients at Higher Risk for Cardiovascular Complications After Percutaneous Coronary Intervention

被引:5
|
作者
Spirito, Alessandro [1 ]
Sharma, Ashutosh [1 ]
Cao, Davide [1 ,2 ]
Sartori, Samantha [1 ]
Zhang, Zhongjie [1 ]
Nicolas, Johny [1 ]
Pivato, Carlo Andrea [2 ]
Cohen, Rebecca [1 ]
Baber, Usman [3 ]
Sweeny, Joseph [1 ]
Sharma, Samin K. [1 ]
Dangas, George [1 ]
Kini, Annapoorna [1 ]
Brener, Sorin J. [4 ]
Mehran, Roxana [1 ]
机构
[1] Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA
[2] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[3] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[4] New York Presbyterian Brooklyn Methodist Hosp, Div Cardiol, Brooklyn, NY USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2023年 / 189卷
关键词
ONE-YEAR MORTALITY; SYNTAX SCORE; DECISION-MAKING; EUROSCORE II; REVASCULARIZATION; VALIDATION; PREDICTION; TRENDS; ACEF;
D O I
10.1016/j.amjcard.2022.11.029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A universal definition to identify patients at higher risk of complications after percutaneous coronary intervention (PCI) is lacking. We aimed to validate a recently developed score to identify patients at increased risk of all-cause death after PCI. All consecutive patients from a large PCI registry not presenting with ST-elevation myocardial infarction or cardiogenic shock were included. Each patient was assigned a score obtained by summing the points associated with the following variables: age > 80 years (3 points), dialysis (6 points), left ventricular ejection fraction < 30% (2 points), and multivessel PCI (2 points). Patients were stratified in 3 groups: low risk (score 0), intermediate risk (score 2 to 3), or high risk (score = 4). The primary outcome was all-cause death, and the secondary outcomes were major adverse cardiovascular events and major bleeding. Events were assessed at 1 year after PCI. Between January 2014 and December 2019, 12,689 patients underwent PCI. Compared with the 9,884 patients at low risk, those at intermediate and high risk had a fourfold (hazard ratio 3.99, 95% confidence interval 2.95 to 5.38) and ninefold (hazard ratio 9.55, 95% confidence interval 6.89 to 13.2) higher hazard for all-cause death at 1 year, respectively. The score had a good predictive value for all-cause death at 1 year (area under the curve 0.70). The risk of major adverse cardiovascular events and major bleeding increased consistently from the low- to the high-risk group. In conclusion, in patients who underwent PCI for stable ischemic heart disease or non-ST-elevation acute coronary syndrome, a score based on 4 variables well predicted the risk of all-cause death at 1 year. (c) 2022 Elsevier Inc. All rights reserved. (Am J Cardiol 2023;189:22-30)
引用
收藏
页码:22 / 30
页数:9
相关论文
共 50 条
  • [21] Bleeding Complications in Patients Undergoing Percutaneous Coronary Intervention
    Galli, Mattia
    Laborante, Renzo
    Andreotti, Felicita
    Vergallo, Rocco
    Montone, Rocco Antonio
    Iaconelli, Antonio
    Trani, Carlo
    Burzotta, Francesco
    Crea, Filippo
    D'Amario, Domenico
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2022, 23 (08)
  • [22] The use of cardiovascular medications in patients with coronary artery disease before and after percutaneous coronary intervention
    Tangsucharit, P.
    Samkaew, T.
    Laowachirasuwan, C.
    Jantaruechai, S.
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2014, 10 (05): : E56 - E56
  • [23] Achilles Tendon Thickening as a Risk Factor of Cardiovascular Events after Percutaneous Coronary Intervention
    Matsumoto, Ichiro
    Kurozumi, Mizuki
    Namba, Tsunetatsu
    Takagi, Yuichiro
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2023, 30 (05) : 491 - 501
  • [24] Troponin Criteria for Myocardial Infarction After Percutaneous Coronary Intervention
    Novack, Victor
    Pencina, Michael
    Cohen, David J.
    Kleiman, Neal S.
    Yen, Chen-Hsing
    Saucedo, Jorge F.
    Berger, Peter B.
    Cutlip, Donald E.
    ARCHIVES OF INTERNAL MEDICINE, 2012, 172 (06) : 502 - 508
  • [25] Incidence and predictors of bleeding complications after percutaneous coronary intervention
    Numasawa, Yohei
    Kohsaka, Shun
    Ueda, Ikuko
    Miyata, Hiroaki
    Sawano, Mitsuaki
    Kawamura, Akio
    Noma, Shigetaka
    Suzuki, Masahiro
    Nakagawa, Susumu
    Momiyama, Yukihiko
    Fukuda, Keiichi
    JOURNAL OF CARDIOLOGY, 2017, 69 (1-2) : 272 - 279
  • [26] Risk Scores of Bleeding Complications in Patients on Dual Antiplatelet Therapy: How to Optimize Identification of Patients at Risk of Bleeding after Percutaneous Coronary Intervention
    Pelliccia, Francesco
    Gragnano, Felice
    Pasceri, Vincenzo
    Cesaro, Arturo
    Zimarino, Marco
    Calabro, Paolo
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (13)
  • [27] Percutaneous coronary intervention in octogenarians: Do they face a higher risk?
    Velazquez, M.
    Hernandez, F.
    Garcia, J.
    Albarran, A.
    Goinez, L.
    Andrea, J.
    Tascon, J.
    Miracle, A.
    Monibiela, T.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (8B): : 77C - 78C
  • [28] External validation of established risk adjustment models for procedural complications after percutaneous coronary intervention
    Kunadian, B.
    Dunning, J.
    Das, R.
    Roberts, A. P.
    Morley, R.
    Turley, A. J.
    Twomey, D.
    Hall, J. A.
    Wright, R. A.
    Sutton, A. G. C.
    Muir, D. F.
    de Belder, M. A.
    HEART, 2008, 94 (08) : 1012 - 1018
  • [29] Intervention study of continuous nursing on recurrent adverse cardiovascular events in patients after percutaneous coronary intervention
    Liu, Qiaoling
    Liu, Zhiping
    Wei, Tanwei
    MINERVA SURGERY, 2023, 78 (03): : 337 - 339
  • [30] Coronary arterial complications after percutaneous coronary intervention in Behcet's disease
    Kinoshita, Toshio
    Fujimoto, Shinichiro
    Ishikawa, Yukio
    Yuzawa, Hitomi
    Fukunaga, Shunji
    Toda, Mikihito
    Wagatsuma, Kenji
    Akasaka, Yoshikiyo
    Ishii, Toshiharu
    Ikeda, Takanori
    RESEARCH REPORTS IN CLINICAL CARDIOLOGY, 2013, 4 : 9 - 12